Lixte Biotechnology Files 8-K on Shareholder Vote Matters
Ticker: LIXT · Form: 8-K · Filed: Dec 11, 2025 · CIK: 1335105
Sentiment: neutral
Topics: corporate-governance, filing-update, shareholder-vote
Related Tickers: LIXT
TL;DR
LIXT filed an 8-K for shareholder vote matters and exhibits. Keep an eye on developments.
AI Summary
Lixte Biotechnology Holdings, Inc. filed an 8-K on December 11, 2025, reporting on events that occurred on December 8, 2025. The filing indicates a submission of matters to a vote of security holders and includes financial statements and exhibits. The company is incorporated in Delaware and its principal executive offices are located in Boca Raton, Florida.
Why It Matters
This filing signals important corporate actions or decisions requiring shareholder approval, which could impact the company's future direction and investor holdings.
Risk Assessment
Risk Level: low — This is a routine filing for an 8-K, primarily reporting on corporate governance and financial disclosures without immediate significant operational changes.
Key Players & Entities
- LIXTE BIOTECHNOLOGY HOLDINGS, INC. (company) — Registrant
- December 8, 2025 (date) — Earliest event reported
- December 11, 2025 (date) — Filing date
- Delaware (jurisdiction) — State of incorporation
- Boca Raton, Florida (location) — Principal executive offices
FAQ
What specific matters were submitted to a vote of security holders?
The filing indicates that matters were submitted to a vote of security holders, but the specific details of these matters are not provided in the excerpt.
What financial statements and exhibits are included with this filing?
The filing states that financial statements and exhibits are included, but the specific content of these documents is not detailed in the provided text.
When was the earliest event reported in this 8-K filing?
The earliest event reported in this 8-K filing occurred on December 8, 2025.
What is the principal executive office address for Lixte Biotechnology Holdings, Inc.?
The principal executive offices are located at 433 Plaza Real, Suite 275, Boca Raton, Florida 33432.
What is the company's telephone number?
The registrant's telephone number, including area code, is (631) 830-7092.
Filing Stats: 786 words · 3 min read · ~3 pages · Grade level 10.3 · Accepted 2025-12-11 14:51:47
Key Financial Figures
- $0.0001 — ch registered Common Stock, par value $0.0001 per share LIXT The NASDAQ Stock Mar
Filing Documents
- form8-k.htm (8-K) — 53KB
- 0001493152-25-027219.txt ( ) — 215KB
- lixt-20251208.xsd (EX-101.SCH) — 3KB
- lixt-20251208_lab.xml (EX-101.LAB) — 33KB
- lixt-20251208_pre.xml (EX-101.PRE) — 22KB
- form8-k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: December 11, 2025 LIXTE BIOTECHNOLOGY HOLDINGS, INC. (Registrant) By: /s/ Geordan Pursglove Geordan Pursglove Chairman of the Board and Chief Executive Officer